We serve Chemical Name:1-(3-methoxyphenyl)-2-thiourea CAS:37014-08-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(3-methoxyphenyl)-2-thiourea
CAS.NO:37014-08-7
Synonyms:5-methoxy phenyl thiourea;3-METHOXYPHENYLTHIOUREA
Molecular Formula:C8H10N2OS
Molecular Weight:182.24300
HS Code:2930909090
Physical and Chemical Properties:
Melting point:160ºC
Boiling point:306.3ºC at 760mmHg
Density:1.287g/cm3
Index of Refraction:1.677
PSA:79.37000
Exact Mass:182.05100
LogP:2.12400
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-methoxy phenyl thiourea chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-METHOXYPHENYLTHIOUREA physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-METHOXYPHENYLTHIOUREA Use and application,5-methoxy phenyl thiourea technical grade,usp/ep/jp grade.
Related News: The monthly injection to suppress the virus that causes AIDS was aimed as an alternative to daily pills. 1-(3-methoxyphenyl)-2-thiourea manufacturer The Transport Security Administration (TSA) will issue a new security directive to airlines from Sunday, according to a person briefed on the restrictions. 1-(3-methoxyphenyl)-2-thiourea supplier Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. 1-(3-methoxyphenyl)-2-thiourea vendor The data will be updated at the upcoming 2019 ASH Annual Meeting next week. 1-(3-methoxyphenyl)-2-thiourea factory Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms.
